Enhancing APE1 may improve therapeutic index of NRTIs

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1326, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HTLV-1 susceptible to several NRTIs

Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Efavirenz + NRTIs most effective for HIV-1 infections

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Meta-analysis of once-daily and twice-daily lopinavir/ritonavir combined with NRTIs in HIV-1-infected, antiretroviral-naive patients

By van Wyk Jean Qaqish Roula Hollar Kimberly White Kelly D’’Amico Ronald Norton Michael Chiu Yi-Lin King Martin

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 103-113

Future Medicine

Access to resources Recommend Favorite

Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 380-392

Bentham Science Publishers

Access to resources Recommend Favorite

Cilansetron may improve IBS symptoms

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite